欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/V/0241/001
药品名称
Laxatract 667 mg/ml oral solution
活性成分
lactulose 667.0 mg/ml
剂型
Oral liquid
上市许可持有人
Dechra Regulatory B.V.
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Germany (DE)
Denmark (DK)
Belgium (BE)
Laxatract 667 mg/ml
Luxembourg (LU)
Iceland (IS)
Laxatract 667 mg/ml saft handa hundum og köttum
Ireland (IE)
Austria (AT)
Laxatract 667 mg/ml Sirup für Hunde und Katzen
France (FR)
LAXATRACT 667 MG/ML SOLUTION BUVABLE POUR CHIENS ET CHATS
Spain (ES)
Portugal (PT)
Italy (IT)
Greece (GR)
Sweden (SE)
Norway (NO)
Laxatract
Finland (FI)
Poland (PL)
Latvia (LV)
Lithuania (LT)
Estonia (EE)
Laxatract
Hungary (HU)
Bulgaria (BG)
Cyprus (CY)
Czechia (CZ)
Laxatract 667 mg/ml sirup pro psy a kočky
Romania (RO)
Slovakia (SK)
Slovenia (SI)
Croatia (HR)
United Kingdom (Northern Ireland) (XI)
许可日期
2018/10/23
最近更新日期
2021/04/23
药物ATC编码
QA06AD11 lactulose
申请类型
TypeLevel1:
non-food
TypeLevel2:
Pharmaceutical
TypeLevel3:
Generic - art 13.2 Dir 2001/82/EC
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Product Information
|
1b_pl_Laxatract_Final
Date of last change:2024/09/06
Final SPC
|
1b_spc_Laxatract_Final
Date of last change:2024/09/06
PubAR
|
proposed PuAR Laxatract
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase